View by Specialty

Headline News

View more

Efruxifermin with GLP-1RA appears safe, reduces liver fat by 65% in MASH, diabetes

March 26, 2024
2 min read
Save

Efruxifermin with GLP-1RA appears safe, reduces liver fat by 65% in MASH, diabetes

Efruxifermin with GLP-1RA appears safe, reduces liver fat by 65% in MASH, diabetes

Efruxifermin with a glucagon-like peptide-1 receptor agonist was well-tolerated and reduced hepatic fat fraction and noninvasive markers of fibrosis among patients with metabolic dysfunction-associated steatohepatitis and type 2 diabetes.

View more Headline News
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails

Resources

View more

Race and Medicine

Racially diverse paper dolls with stethoscope

This collection seeks to bring together research on racial disparities across our specialties along with perspectives from physicians from various racial backgrounds.

View resource

Opioid Resource Center

200332_Opioid_RC_OG

A collection of news articles and features focused on the opioid crisis, which has been declared a public health emergency.

View resource

Food is Medicine

Nutrition RC OG

A collection of news articles and features that explore the impact of food and beverages on the body.

View resource
View more Resources
View more Meeting News
View meeting calendar

Podcasts

View more
Hematology/Oncology Oncology Overdrive
July 20, 2020
47 min listen

The Impact of Jail Cycling Amid a Pandemic

Hematology/Oncology Oncology Overdrive
July 13, 2020
40 min listen

Doctors on Social Media

Rheumatology
View more Podcasts

Blogs & Columns

View more
Edward V. Loftus Jr.

Editorials

with Edward V. Loftus Jr., MD

Opinions on important issues that affect gastroenterology and hepatology practice.

Experts discuss the latest news in hepatitis C.
View more Blogs & Columns